SILEXION THERAPEUTICS CORP Other Accounts Payable and Accrued Liabilities
SILEXION THERAPEUTICS CORP (SLXN) had Other Accounts Payable and Accrued Liabilities of $910.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Payables and Accruals
us-gaap:OtherAccountsPayableAndAccruedLiabilities · last filed 2026-03-17
- 2025-12-31: Other Accounts Payable and Accrued Liabilities $910.00K.
- 2025-09-30: Other Accounts Payable and Accrued Liabilities $945.00K.
- 2025-06-30: Other Accounts Payable and Accrued Liabilities $659.00K.
- 2025-03-31: Other Accounts Payable and Accrued Liabilities $893.00K.
| Period end | Other Accounts Payable and Accrued Liabilities |
|---|---|
| 2025-12-31 | $910.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $945.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $659.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $893.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $788.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $1.86M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.38M 10-Q · filed 2024-08-29 |
| 2023-12-31 | $1.36M 8-K · filed 2025-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |